Identification and characterization of a spinal muscular atrophy-determining gene, Cell, vol.80, pp.155-165, 1995. ,
The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells, Exp. Cell Res, vol.256, pp.365-374, 2000. ,
Spinal muscular atrophy: the RNP connection, Trends Mol. Med, vol.12, pp.113-121, 2006. ,
Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study, PLoS ONE, vol.7, p.33572, 2012. ,
A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy, Proc. Natl Acad. Sci. USA, vol.96, pp.6307-6311, 1999. ,
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?, Nat. Rev. Neurosci, vol.10, pp.597-609, 2009. ,
The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy, Hum. Mol. Genet, vol.9, pp.333-339, 2000. ,
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy, Science, vol.345, pp.688-693, 2014. ,
SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice, Nat. Chem. Biol, vol.11, pp.511-517, 2015. ,
Spinal muscular atrophy: development and implementation of potential treatments, Ann. Neurol, vol.74, pp.348-362, 2013. ,
Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy, Future Med. Chem, vol.7, pp.1793-1808, 2015. ,
Advances in therapeutic development for spinal muscular atrophy, Future Med. Chem, vol.6, pp.1081-1099, 2014. ,
Spinal muscular atrophy therapeutics: where do we stand?, Neurotherapeutics, vol.12, pp.303-316, 2015. ,
Discovery and optimization of small molecule splicing modifiers of survival motor neuron 2 as a treatment for spinal muscular atrophy, J. Med. Chem, vol.59, pp.6070-6085, 2016. ,
Alternative splicing in spinal muscular atrophy underscores the role of an intron definition model, RNA Biol, vol.8, pp.600-606, 2011. ,
Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes, Nucleic Acids Res, vol.35, pp.371-389, 2007. ,
Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions, Ann. N. Y. Acad. Sci, vol.1341, pp.176-187, 2015. ,
Methods to enable the design of bioactive small molecules targeting RNA, Org. Biomol. Chem, vol.12, pp.1029-1039, 2014. ,
Recent advances in developing small molecules targeting RNA, ACS Chem. Biol, vol.7, pp.73-86, 2012. ,
Targeting RNA with small molecules, Chem. Rev, vol.108, pp.1171-1224, 2008. ,
Role of RNA structure in regulating pre-mRNA splicing, Trends Biochem. Sci, vol.35, pp.169-178, 2010. ,
2-Aminopurine fluorescence quenching and lifetimes: role of base stacking, Proc. Natl Acad. Sci. USA, vol.98, pp.37-41, 2001. ,
Identifying the preferred RNA motifs and chemotypes that interact by probing millions of combinations, Nat. Commun, vol.3, p.1125, 2012. ,
A modified fluorescent intercalator displacement assay for RNA ligand discovery, Anal. Biochem, vol.408, pp.269-276, 2011. ,
A simple statistical parameter for use in evaluation and validation of high throughput screening assays, J. Biomol. Screen, vol.4, pp.67-73, 1999. ,
An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA, Gene Ther, vol.8, pp.1532-1538, 2001. ,
Evolutionary conservation of vertebrate blood-brain barrier chemoprotective mechanisms in Drosophila, J. Neurosci, vol.29, pp.3538-3550, 2009. ,
Neuromuscular defects in a Drosophila survival motor neuron gene mutant, Hum. Mol. Genet, vol.12, pp.1367-1376, 2003. ,
SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing, Cell, vol.133, pp.585-600, 2008. ,
Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy, PLoS Genet, vol.5, p.1000773, 2009. ,
Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy, Proc. Natl Acad. Sci. USA, vol.110, pp.19348-19353, 2013. ,
Splicing changes in SMA mouse motoneurons and SMNdepleted neuroblastoma cells: evidence for involvement of splicing regulatory proteins, RNA Biol, vol.11, pp.1430-1446, 2014. ,
Adenylate kinase motions during catalysis: an energetic counterweight balancing substrate binding, Structure, vol.4, pp.147-156, 1996. ,
Conserved RNA secondary structures promote alternative splicing, RNA, vol.14, pp.1463-1469, 2008. ,
RNA mis-splicing in disease, Nat. Rev. Genet, vol.17, pp.19-32, 2016. ,
RNA splicing: disease and therapy, Brief Funct. Genom, vol.10, pp.151-164, 2011. ,
Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization, Nucleic Acids Res, vol.35, pp.4250-4263, 2007. ,
Aberrant 3' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization, Nucleic Acids Res, vol.34, pp.4630-4641, 2006. ,
Biased exon/intron distribution of cryptic and de novo 3' splice sites, Nucleic Acids Res, vol.33, pp.4882-4898, 2005. ,
Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17, Proc. Natl Acad. Sci. USA, vol.96, pp.8229-8234, 1999. ,
A native RNA secondary structure controls alternative splice-site selection and generates two human growth hormone isoforms, J. Biol. Chem, vol.267, pp.14902-14908, 1992. ,
Bottom-up design of small molecules that stimulate exon 10 skipping in mutant MAPT pre-mRNA, Chembiochemistry, vol.15, pp.2041-2044, 2014. ,
Template-directed synthesis of a small molecule-antisense conjugate targeting an mRNA structure, Bioorg. Chem, vol.54, pp.7-11, 2014. ,
Structure-based development of target-specific compound libraries, Drug Discov. Today, vol.11, pp.261-266, 2006. ,
The design and application of target-focused compound libraries, Comb. Chem. High. Throughput Screen, vol.14, pp.521-531, 2011. ,
Design and implementation of an ribonucleic acid (RNA) directed fragment library, J. Med. Chem, vol.52, pp.3753-3761, 2009. ,
Altered mRNA splicing in SMN-depleted motor neuronlike cells, PLoS ONE, vol.11, p.163954, 2016. ,
The G×U wobble base pair. A fundamental building block of RNA structure crucial to RNA function in diverse biological systems, EMBO Rep, vol.1, pp.18-23, 2000. ,
The role of short RNA loops in recognition of a single-hairpin exon derived from a mammalian-wide interspersed repeat, RNA Biol, vol.12, pp.54-69, 2015. ,
Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein, Proc. Natl Acad. Sci. USA, vol.106, pp.11931-11936, 2009. ,
Rational design of chemical genetic probes of RNA function and lead therapeutics targeting repeating transcripts, Drug Discov. Today, vol.18, pp.1228-1236, 2013. ,
Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1), J. Am. Chem. Soc, vol.130, pp.16254-16261, 2008. ,
Pentamidine reverses the splicing defects associated with myotonic dystrophy, Proc. Natl Acad. Sci. USA, vol.106, pp.18551-18556, 2009. ,
Design of a small molecule against an oncogenic noncoding RNA, Proc. Natl Acad. Sci. USA, vol.113, pp.5898-5903, 2016. ,
Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble, Nat. Chem. Biol, vol.7, pp.553-559, 2011. ,
Amiloride as a new RNA-binding scaffold with activity against HIV-1 TAR, MedChemComm, vol.8, pp.1022-1036, 2017. ,